E75.28
Canavan disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Canavan disease is a rare, inherited neurological disorder that primarily affects infants and young children. It progressively damages the brain's nerve cells, leading to severe developmental delays and neurological issues. Understanding this condition is essential for awareness and early intervention, although there is currently no cure.
Causes & Symptoms
Clinical Causes: Genetic mutation in the ASPA gene Inheritance pattern: autosomal recessive Both parents must carry the faulty gene for their child to be affected
Key Symptoms: Poor motor development and declining muscle strength Enlarged head (macrocephaly) Poor muscle tone (hypotonia) Loss of developmental milestones Feeding difficulties Seizures Visual impairments Progressive loss of motor skills
Diagnostic & Treatment
Diagnosis Path: Magnetic resonance imaging (MRI) to observe brain abnormalities Genetic testing to identify ASPA gene mutations Ongoing developmental assessments
Treatment Protocols: Physical therapy to maintain motor skills Nutritional support and feeding assistance Medications to control seizures Supportive care to address developmental and nutritional needs Palliative care options for comfort and support
Clinical Advice & FAQs
Billing Guidance
Is E75.28 a billable ICD-10 code?
Yes, E75.28 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E75.28?
Clinical documentation must specify the nature of Canavan disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference